NCT00475202

Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: —
• Sponsor: Assaf-Harofeh Medical Center · Other Government
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Diabetic foot ulcers are a major cause of morbidity and mortality, accounting for approximately two-thirds of all non-traumatic amputations performed in the United States. The cost of foot ulcers in diabetic patients averages almost $28,000 for the two years after diagnosis of the ulcer. Hyperbaric oxygen (HBO) serves as primary or adjunctive therapy for a diverse range of medical conditions. HBO also has been used as an adjunct to antibiotics, debridement, and revascularization in the therapy of chronic, nonhealing wounds associated with diabetes or non-diabetic vascular insufficiency. The aim of the study is to assess whether hyperoxia induced angiogenesis in diabetic patients with foot ulcers.

Conditions

• Diabetic Foot Ulcers
• Hyperbaric Therapy
• Angiogenesis

Timeline

• First posted: 2007-05-21
• Last updated: 2007-05-21

Locations

1 site across 1 country: Israel